APA (7th ed.) Citation

K, F., NW, C., M, D. S., H, U., AP, F., N, K., . . . DJ, G. (2026). Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study. Annals of oncology : official journal of the European Society for Medical Oncology, 37(1), 53. https://doi.org/10.1016/j.annonc.2025.10.004

Chicago Style (17th ed.) Citation

K, Fizazi, et al. "Capivasertib Plus Abiraterone in PTEN-deficient Metastatic Hormone-sensitive Prostate Cancer: CAPItello-281 Phase III Study." Annals of Oncology : Official Journal of the European Society for Medical Oncology 37, no. 1 (2026): 53. https://doi.org/10.1016/j.annonc.2025.10.004.

MLA (9th ed.) Citation

K, Fizazi, et al. "Capivasertib Plus Abiraterone in PTEN-deficient Metastatic Hormone-sensitive Prostate Cancer: CAPItello-281 Phase III Study." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 37, no. 1, 2026, p. 53, https://doi.org/10.1016/j.annonc.2025.10.004.